Sorry, you need to enable JavaScript to visit this website.
Skip to main content
This section of the global Janssen website provides a company overview in several languages. It is not targeted to any specific audience or country. Click here for country- and region-specific information of interest.
 
Janssen’s COVID-19 Vaccine Status >
 
 
 
MENU CLOSE
 

JANSSEN GLOBAL
CHANGE LOCATION >

Search
Search
Home › Focus on Schizophrenia Research

Focus on Schizophrenia Research

Schizophrenia
  • Schizophrenia Research at Janssen
Our Areas of Interest for Collaboration
Novel Therapies in Phase 2b or Later for Symptomatic Treatment of the Underlying Symptoms of Schizophrenia with Special Emphasis on Treatment of Cognitive Impairment and Negative Symptoms.Biomarkers and Integrated Solutions
  • Prognostic biomarkers to identify patients at risk for disease
  • Predictive biomarkers for treatment response
  • Integrated solutions for patient diagnosis or treatment assessment
  • Cognitive tests for measuring disease progression

Neuroscience

Neuroscience

Nerve fibers
Nerve fibers